Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Malignant Lymphoma

  Free Subscription


Articles published in J Immunol

Retrieve available abstracts of 10 articles:
HTML format
Text format



Single Articles


    September 2019
  1. ZHANG Q, Wang HY, Liu X, Nunez-Cruz S, et al
    Cutting Edge: ROR1/CD19 Receptor Complex Promotes Growth of Mantle Cell Lymphoma Cells Independently of the B Cell Receptor-BTK Signaling Pathway.
    J Immunol. 2019 Sep 18. pii: jimmunol.1801327. doi: 10.4049/jimmunol.1801327.
    PubMed     Text format     Abstract available


    June 2019
  2. GUTZEIT C, Nagy N, Gentile M, Lyberg K, et al
    Correction: Exosomes Derived from Burkitt's Lymphoma Cell Lines Induce Proliferation, Differentiation, and Class-Switch Recombination in B Cells.
    J Immunol. 2019 Jun 21. pii: jimmunol.1900638. doi: 10.4049/jimmunol.1900638.
    PubMed     Text format    


    August 2018
  3. DI PIETRO A, Good-Jacobson KL
    Disrupting the Code: Epigenetic Dysregulation of Lymphocyte Function during Infectious Disease and Lymphoma Development.
    J Immunol. 2018;201:1109-1118.
    PubMed     Text format     Abstract available


    June 2018
  4. HAYAKAWA K, Formica AM, Nakao Y, Ichikawa D, et al
    Early Generated B-1-Derived B Cells Have the Capacity To Progress To Become Mantle Cell Lymphoma-like Neoplasia in Aged Mice.
    J Immunol. 2018 Jun 13. pii: jimmunol.1800400. doi: 10.4049/jimmunol.1800400.
    PubMed     Text format     Abstract available


    May 2018
  5. GIRARDI M, Oppenheim DE, Steele CR, Lewis JM, et al
    Pillars Article: Regulation of Cutaneous Malignancy by gammadelta T Cells. Science. 2001. 294: 605-609.
    J Immunol. 2018;200:3031-3035.
    PubMed     Text format    


    April 2018
  6. PALAZZO A, Herter S, Grosmaire L, Jones R, et al
    The PI3Kdelta-Selective Inhibitor Idelalisib Minimally Interferes with Immune Effector Function Mediated by Rituximab or Obinutuzumab and Significantly Augments B Cell Depletion In Vivo.
    J Immunol. 2018;200:2304-2312.
    PubMed     Text format     Abstract available


    December 2017
  7. WASIUK A, Testa J, Weidlick J, Sisson C, et al
    CD27-Mediated Regulatory T Cell Depletion and Effector T Cell Costimulation Both Contribute to Antitumor Efficacy.
    J Immunol. 2017;199:4110-4123.
    PubMed     Text format     Abstract available


    November 2017
  8. CATALAN-DIBENE J, Vazquez MI, Luu VP, Nuccio SP, et al
    Identification of IL-40, a Novel B Cell-Associated Cytokine.
    J Immunol. 2017;199:3326-3335.
    PubMed     Text format     Abstract available


    October 2017
  9. BERTOCCI B, Lecoeuche D, Sterlin D, Kuhn J, et al
    Klhl6 Deficiency Impairs Transitional B Cell Survival and Differentiation.
    J Immunol. 2017;199:2408-2420.
    PubMed     Text format     Abstract available


    April 2017
  10. LI J, Roy S, Kim YM, Li S, et al
    Id2 Collaborates with Id3 To Suppress Invariant NKT and Innate-like Tumors.
    J Immunol. 2017;198:3136-3148.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Lymphoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: